M. Loghmanadham et al., ENHANCED BIOAVAILABILITY OF PHOSPHONOFORMIC ACID BY DIETARY PHOSPHORUS RESTRICTION, Biochemical pharmacology, 48(7), 1994, pp. 1455-1458
Phosphonoformic acid (PFA, foscarnet) is a potent inhibitor of Na+-P-i
cotransport in intestinal and renal brush border membranes (BBM). We
have studied the effect of dietary phosphorus restriction on intestina
l PFA absorption and bioavailability. Rats were placed on low (0.04% P
-i, LPD) or normal (0.95% P-i, NPD) phosphorus diets for 5 days, follo
wed by administration of an oral bolus of [C-14]PFA (100 mg/kg). Of th
e oral PFA dose, 60 +/- 4% was absorbed in LPD rats, compared with 43
+/- 3% in NPD rats (P < 0.05, N = 5). This was associated with higher
plasma PFA concentrations in LPD compared with NPD rats (44.2 +/- 2.0
and 17.9 +/- 4.3 mu g/mL, respectively). [C-14]PFA uptake, determined
in intestinal BBM vesicles (BBMV), was Na+ gradient (Na-out(+) > Na-in
(+)) dependent. Dietary phosphorus restriction resulted in a 39.8% inc
rease in the initial (1 min) Na+-dependent [C-14]PFA uptake by intesti
nal BBMV. We conclude that PFA absorption is enhanced by dietary phosp
horus restriction.